KURA

Kura Oncology, Inc.

SEC CIK 1422143
$9.05 +12.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$154.8K
4 open-market
Net insider flow
−$154.8K
Net selling
Filings shown
69
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at KURA have sold a net $154.8K of stock (0 open-market buys vs 4 sells).

Largest recent trade: Wilson Troy Edward sold $3.63M of KURA, trimming their stake 100%.

Most active filer: Wilson Troy Edward, with 24 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for KURA, newest first
View on SEC EDGAR ↗
KURA
Sell GRASSO MARC · CFO, CBO · Open-market sale · filed Sep 10, 2020 ΔOwn −100%

Grasso Marc sold $260K of KURA, trimming their stake 100%.

−$260K
10,000 sh @ $26
KURA
Sell WILSON TROY EDWARD · Director, President and CEO · Open-market sale · filed Aug 26, 2020 ΔOwn −45%

Wilson Troy Edward sold $515.8K of KURA, trimming their stake 45%.

−$515.8K
23,053 sh @ $22
KURA
Sell GRASSO MARC · CFO, CBO · Open-market sale · filed Aug 26, 2020 ΔOwn −100%

Grasso Marc sold $230K of KURA, trimming their stake 100%.

−$230K
10,000 sh @ $23
KURA
Sell WILSON TROY EDWARD · Director, President and CEO · Open-market sale · filed Aug 26, 2020 ΔOwn −19%

Wilson Troy Edward sold $144.8K of KURA, trimming their stake 19%.

−$144.8K
6,568 sh @ $22
KURA
Sell WILSON TROY EDWARD · Director, President and CEO · Open-market sale · filed Aug 19, 2020 ΔOwn −30%

Wilson Troy Edward sold $263.2K of KURA, trimming their stake 30%.

−$263.2K
11,913 sh @ $22
Advertisement
KURA
Sell WILSON TROY EDWARD · Director, President and CEO · Open-market sale · filed Aug 19, 2020 ΔOwn −1.8%

Wilson Troy Edward sold $11.5K of KURA, trimming their stake 2%.

−$11.5K
521 sh @ $22
KURA
Sell WILSON TROY EDWARD · Director, President and CEO · Open-market sale · filed Aug 19, 2020 ΔOwn −12%

Wilson Troy Edward sold $1.1M of KURA, trimming their stake 12%.

−$1.1M
50,000 sh @ $22
KURA
Sell WILSON TROY EDWARD · Director, President and CEO · Open-market sale · filed Aug 19, 2020 ΔOwn −31%

Wilson Troy Edward sold $283.9K of KURA, trimming their stake 31%.

−$283.9K
12,901 sh @ $22
KURA
Sell GRASSO MARC · CFO, CBO · Open-market sale · filed Aug 11, 2020 ΔOwn −100%

Grasso Marc sold $200K of KURA, trimming their stake 100%.

−$200K
10,000 sh @ $20
Advertisement

About KURA insider activity

This page tracks every recent Form 4 filed for Kura Oncology, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is KURA insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Kura Oncology, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.